v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net loss $ (12,461) $ (35,782)
Less: net loss from discontinued operations, net of tax 0 8,832
Net loss from continuing operations (12,461) (26,950)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 4,585 5,479
Unrealized gain foreign currency (501) (46)
Stock based compensation 1,377 704
Change in fair value of warrants (1,234) 37
Amortization of debt discount and deferred issuance costs 546 489
Deferred income tax 3 493
Provision for doubtful accounts (129) (74)
Non-cash lease expense 4,716 4,261
Changes in operating assets and liabilities:    
Accounts receivable 13,131 28,912
Prepaid expenses and other current assets (3,163) 1,085
Accounts payable (6,886) (23,184)
Accrued compensation 1,372 6,253
Accrued expenses, other current liabilities, and other liabilities 4,277 3,315
Lease liabilities (5,952) (5,115)
Deferred revenue 1,663 488
Cash provided by (used in) operating activities from continuing operations 1,344 (3,853)
Cash used in operating activities from discontinued operations 0 (9,446)
Cash provided by (used in) operating activities from continuing operations 1,344 (13,299)
Investing activities:    
Capital expenditures (388) (88)
Capitalization of internal-use software (3,128) (3,330)
Business combination, net of cash acquired (233) 0
Proceeds from sale of asset 300 0
Cash used in investing activities from continuing operations (3,449) (3,418)
Cash provided by investing activities from discontinued operations 0 108,575
Cash (used in) provided by investing activities (3,449) 105,157
Financing activities:    
Payment for shares withheld for employee taxes (25) 0
Borrowings on Revolving Credit Facility 0 (33,837)
Payment of consent solicitation fees (2,089) 0
Payment on Convertible Notes (285) (30,900)
Proceeds from the issuance of common stock in connection with the at-the-market offering, net of issuance costs (55) 0
Payment of early termination fee for Revolving Credit Facility 0 (500)
Payment of deferred issuance costs 0 (591)
Cash used in financing activities (2,454) (65,828)
Effect of currency translation on cash and cash equivalents 237 (160)
Net (decrease) increase in cash and cash equivalents (4,322) 25,870
Cash and cash equivalents at beginning of period 38,648 35,637
Cash and cash equivalents and restricted cash at end of period $ 34,326 $ 61,507